Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kevin Accola

Thoracic Surgery (Cardiothoracic Vascular Surgery) Orlando, FL Medical Doctor

NPI 1760488431 CMS profile 216440

217 Hillcrest St, Orlando, FL 32801

Open in the dashboard

General payments

$312,858

305 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,347,294 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Kevin Accola of Orlando, FL is reported in the CMS Open Payments database as having received $312,858 across 305 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,347,294 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $54,815 59
2024 General $56,733 47
2023 General $66,320 57
2022 General $43,219 43
2021 General $15,225 17
2020 General $22,789 21
2019 General $53,757 61

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kevin Accola
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Kevin Accola were reported at $54,815. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Kevin Accola Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $53,757 $886 $178–$3,167 $163
2020 $22,789 $341 $108–$1,605 $114
2021 $15,225 $453 $125–$1,886 $132
2022 $43,219 $695 $180–$2,566 $149
2023 $66,320 $745 $205–$2,662 $160
2024 $56,733 $799 $214–$2,967 $164
2025 $54,815 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $306,643 240 payments
  2. Atricure, Inc. $4,381 13 payments
  3. Abbott Laboratories $577 8 payments
  4. CryoLife, Inc. $250 15 payments
  5. Wright Medical Technology, Inc. $237 3 payments
  6. Medtronic Vascular, Inc. $146 3 payments
  7. Medtronic, Inc. $144 1 payment
  8. Portola Pharmaceuticals, Inc. $88 5 payments
  9. Intuitive Surgical, Inc. $88 1 payment
  10. Teleflex LLC $86 4 payments
  11. Other $217 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $254,963 68 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $25,492 7 payments
  3. Travel and Lodging $23,879 49 payments
  4. Food and Beverage $8,523 180 payments
  5. Education $1 1 payment
Products named General payments · program years 2019–2025
  1. MITRIS RESILIA Mitral Valve $16,335 73 payments
  2. Carpentier-Edwards PERIMOUNT Magna Mitral Ease Pericardial Valve $12,841 5 payments
  3. EDWARDS INTUITY Elite valve system $12,825 3 payments
  4. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $3,528 3 payments
  5. INSPIRIS RESILIA AORTIC VALVE $1,609 2 payments
  6. ATRICLIP LAA EXCLUSION SYSTEM $770 7 payments
  7. SYNERGY ABLATION SYSTEM $389 7 payments
  8. ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER $250 15 payments
  9. BIOGLUE SURGICAL ADHESIVE $250 15 payments
  10. Cardiac non-SynerGraft $232 14 payments
  11. Other $3,130 85 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$324,667

Medicare's payments for the services billed

Medicare patients

185

Average age 77

Services billed

381

102 women, 83 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 75%
Atrial fibrillation 65%
Arthritis 63%
Chronic kidney disease 50%
Diabetes 47%
COPD 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

305 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record